Gut Microbiome
0
Pipeline Programs
3
Companies
4
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Colorado TherapeuticsCO - Louisville
3 programsBaby Foods - MeatN/A1 trial
InkomaziN/A1 trial
Wild SalmonN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
2028
2029
Colorado TherapeuticsInkomazi
Oregon TherapeuticsGarden-fresh Produce
Colorado TherapeuticsBaby Foods - Meat
Colorado TherapeuticsWild Salmon
Clinical Trials (4)
Total enrollment: 399 patients across 4 trials
Developing Interventions for Protecting HIV-Exposed Uninfected Infants Against Severe Infections
Start: Apr 2025Est. completion: Jul 202972 patients
N/AEnrolling By Invitation
Garden-fresh Foods and Gut Microbiomes
Start: Jul 2023Est. completion: Dec 202420 patients
N/ARecruiting
Effects of Complementary Feeding on Infant Growth and Gut Health
Start: Aug 2021Est. completion: Jul 2027267 patients
N/AActive Not Recruiting
Salmon Intake and Gut Health in Adults
Start: Aug 2021Est. completion: Apr 202340 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 399 patients
3 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.